Almaden Genomics Introduces g.nome® 2.0, a Platform Enhancement to Empower Data Analysis and Interpretation
January 13, 2025
Almaden Genomics has launched g.nome 2.0, enhancing bioinformatics tools with advanced analytics and a streamlined interface for researchers and biologists.
Read More »
BioNTX Unveils 2024 Rising Stars at the iC³® Life Science & Healthcare Innovation Summit
October 1, 2024
Almaden is recognized among the groundbreaking companies honored as 2024 Rising Stars at the iC³ Life Science & Healthcare Innovation Summit.
Read More »
Almaden Launches New Data Management and Informatics Service Business
September 17, 2024
Almaden Genomics has launched a new Data Management and Informatics Services business to support its bioinformatics and computational biology solutions.
Read More »
Almaden Genomics and Elucidata Pair g.nome® with Polly
March 19, 2024
Almaden Genomics partners with Elucidata to integrate Polly’s data harmonization engine into g.nome®, enhancing the solution's dataset diversity and accelerating omics data analysis.
Read More »
Almaden & BigOmics: Omics Data Collaboration
February 22, 2024
Almaden Genomics and BigOmics collaborate to provide end-to-end omics data analysis, integrating Omics Playground with g.nome® for accelerated insights.
Read More »
Almaden Genomics’ g.nome® Further Enhances Single-Cell Analysis
December 13, 2023
Almaden Genomics has incorporated an end-to-end solution to process, analyze, and visualize single-cell RNAseq data.
Read More »
Almaden Adds Pre-built Workflows for faster scRNA-Seq Analysis
October 3, 2023
Almaden Genomics has introduced pre-built workflows for single-cell RNA-seq analysis. This game-changing feature empowers researchers to delve deeper into cellular diversity and disease mechanisms.
Read More »
Almaden Builds Business Operations to Catch up With Technology
June 28, 2023
Almaden Genomics building business operations to keep up with technological innovation
Read More »
Almaden Names Ellen Gordon VP, Head of Business Development
June 6, 2023
Almaden Genomics has named Ellen Gordon as VP, Head of Business Development. She will help Almaden partner with clients to accelerate genomic research.
Read More »